True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
"cd8-positive, alpha-beta t cell",Cytotoxic Lymphocytes,"Activated/Tissue-Resident Gamma-Delta T Cells (γδ T cells) with Cytotoxic Potential, Activated/Tissue-Resident CD8+ Cytotoxic T Lymphocytes (CTLs), Natural Killer (NK) Cells","NK cells, CD8+ T cells, gamma-delta T cells",50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: **Step 1: List the Key Functional Markers** This list is rich in genes associated with cytotoxic function, immune activation, and chemokine signaling. * **Cytotoxicity & Granule-associated proteins:** * **GZMH, GZMA, GZMB, GZMK, GZMM:** Granzymes are serine proteases found in the granules of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. They induce apoptosis in target cells. GZMB is a particularly strong indicator of cytotoxic activity. * **PRF1 (Perforin 1):** A pore-forming protein crucial for the delivery of granzymes into target cells, a hallmark of cytotoxic lymphocytes. * **NKG7:** A transmembrane protein found in the granules of NK cells and CTLs, involved in granule exocytosis. * **CTSW (Cathepsin W):** A cysteine protease expressed in NK cells and CTLs, potentially involved in granule maturation or processing. * **Chemokines & Chemokine Receptors:** * **XCL2, XCL1:** Lymphotactin (XCL1/2) are C-motif chemokines primarily produced by NK cells and cytotoxic T cells, attracting other immune cells. * **CCL4, CCL4L2, CCL5:** C-C motif chemokines involved in recruiting various immune cells, including NK cells, T cells, and monocytes, to sites of inflammation. CCL5 (RANTES) is a potent chemoattractant. * **Cytokines & Cytokine Receptors:** * **IFNG (Interferon Gamma):** A potent pro-inflammatory cytokine produced by NK cells and T cells, crucial for antiviral and antitumor immunity. * **IL21R (Interleukin 21 Receptor):** IL-21 is important for NK cell and T cell differentiation and function. * **Immune Checkpoints & Co-stimulatory/Inhibitory Molecules:** * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on NK cells and T cells, involved in immune regulation. * **LAG3 (Lymphocyte-activation gene 3):** An inhibitory receptor expressed on activated T cells and NK cells, contributing to immune exhaustion. * **TNFRSF9 (CD137/4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, promoting their survival and proliferation. * **Signaling & Adaptor Proteins:** * **SH2D1A (SLAM-associated protein, SAP):** An adaptor protein critical for NK cell and T cell activation and cytotoxicity, particularly in NKT cells. * **PTPN22:** A phosphatase involved in regulating T cell activation. * **DUSP4:** A dual-specificity phosphatase involved in regulating MAPK signaling, often associated with immune cell activation. **Step 2: List the Key Cell Type Markers** This list strongly points towards cytotoxic lymphocytes, specifically NK cells and cytotoxic T cells, with some indications of gamma-delta T cells. * **Natural Killer (NK) Cell Markers:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2F), KLRD1 (CD94):** These are C-type lectin-like receptors characteristic of NK cells. NKG2D (KLRK1) is a major activating receptor on NK cells. CD94 (KLRD1) forms heterodimers with NKG2A, C, E, and F. * **CD160:** A receptor expressed on NK cells and cytotoxic T cells, involved in cytotoxicity. * **NKG7:** As mentioned above, a granule protein highly expressed in NK cells and CTLs. * **Cytotoxic T Lymphocyte (CTL) Markers:** * **CD8B, CD8A:** Components of the CD8 co-receptor, defining cytotoxic T lymphocytes (CD8+ T cells). The presence of both CD8A and CD8B strongly indicates CD8+ T cells. * **Gamma-Delta T Cell Markers:** * **TRGC2, TRGC1:** T cell receptor gamma chain constant regions, indicating gamma-delta T cells. Gamma-delta T cells are a distinct lineage of T cells, often found in epithelial tissues, and can exhibit cytotoxic functions. * **General Lymphocyte/Immune Cell Markers:** * **CD7:** A pan-T cell marker, also expressed on NK cells and some B cells. * **GPR18:** A G protein-coupled receptor expressed on various immune cells, including T cells and NK cells. * **TMIGD2 (CD28H):** A co-stimulatory molecule expressed on T cells and NK cells. * **IKZF2 (Helios):** A transcription factor expressed in regulatory T cells (Tregs) and some activated conventional T cells, but its presence here alongside strong cytotoxic markers might indicate a specific activated T cell subset. * **LAYN:** A hyaluronan-binding protein, often associated with activated T cells, including exhausted T cells. **Step 3: Cross-reference Known Databases** A quick mental cross-reference with common scRNA-seq atlases (e.g., Human Cell Atlas, specific gut atlases) and literature confirms that the co-expression of: * **Granzymes (GZMA, GZMB, GZMH, GZMK, GZMM) and Perforin (PRF1)** * **NK cell receptors (KLRC2, KLRK1, KLRC4, KLRD1)** * **CD8 (CD8A, CD8B)** * **Chemokines (XCL1, XCL2, CCL4, CCL5)** * **IFNG** * **TRGC1/TRGC2** ...is highly characteristic of **cytotoxic lymphocytes**, specifically overlapping populations of **NK cells, CD8+ T cells, and gamma-delta T cells**, often found in activated or tissue-resident states, particularly in mucosal tissues like the large intestine. The presence of both CD8 and NK cell markers suggests either a mixed population or a specific subset with overlapping features (e.g., NKT-like cells, or activated CD8+ T cells expressing some NK receptors). The strong presence of TRGC1/TRGC2 is a key differentiator. **Step 4: Determine the Most Probable General Cell Type** Based on the overwhelming presence of cytotoxic granule proteins (granzymes, perforin), NK cell receptors, CD8, and T cell receptor gamma chains, the most probable general cell type is **Cytotoxic Lymphocytes**. **Step 5: Identify the Top 3 Most Probable Sub Cell Types** 1. **Most Likely: Activated/Tissue-Resident Gamma-Delta T Cells (γδ T cells) with Cytotoxic Potential.** * **Reasoning:** The strong and specific expression of **TRGC1** and **TRGC2** is a definitive marker for gamma-delta T cells. These cells are abundant in mucosal tissues like the large intestine and are known to exhibit potent cytotoxic functions, often expressing granzymes (GZMA, GZMB, GZMH, PRF1) and NK cell receptors (e.g., KLRK1/NKG2D, CD160, KLRC2/NKG2C). The presence of CD8A/B in gamma-delta T cells is also known, as a subset of γδ T cells can express CD8. The chemokines (XCL1, XCL2, CCL4, CCL5) and IFNG further support their activated, effector role. The immune checkpoints (TIGIT, LAG3) suggest an activated or potentially exhausted state, common for tissue-resident lymphocytes. 2. **Second Most Likely: Activated/Tissue-Resident CD8+ Cytotoxic T Lymphocytes (CTLs).** * **Reasoning:** The clear presence of **CD8A** and **CD8B** is a hallmark of CD8+ T cells. The high expression of **granzymes (GZMA, GZMB, GZMH, GZMK, GZMM), PRF1, NKG7, IFNG, XCL1, XCL2, CCL4, CCL5** are all classic markers of activated, cytotoxic CD8+ T cells. Some NK cell receptors (like KLRK1/NKG2D, CD160) can also be expressed on activated CD8+ T cells, particularly tissue-resident memory T cells (TRM). The presence of TRGC1/TRGC2 makes this less likely to be *pure* conventional CD8+ T cells, but a subset could co-express these. 3. **Third Most Likely: Natural Killer (NK) Cells.** * **Reasoning:** The robust expression of multiple **NK cell receptors (KLRC2, KLRK1, KLRC4, KLRD1, CD160)**, along with **granzymes, PRF1, NKG7, XCL1, XCL2, CCL4, CCL5, and IFNG**, are all highly characteristic of NK cells. However, the strong presence of **CD8A/B** and especially **TRGC1/TRGC2** makes a pure NK cell annotation less probable than the gamma-delta or CD8+ T cell options, suggesting either a mixed population or a cell type with NK-like features. **Most Likely Subtype:** Given the definitive markers **TRGC1** and **TRGC2** alongside the strong cytotoxic and NK-like receptor profile, the most likely specific subtype is **Activated/Tissue-Resident Gamma-Delta T Cells with Cytotoxic Potential.** These cells are known to be abundant in the gut, express cytotoxic machinery, and can co-express some NK cell receptors and even CD8. **Step 6: Provide a Concise Summary of Your Analysis** This cell cluster exhibits a highly activated and cytotoxic phenotype, characterized by the robust expression of multiple granzymes (GZMA, GZMB, GZMH, GZMK, GZMM), perforin (PRF1), and the granule protein NKG7. The presence of chemokines (XCL1, XCL2, CCL4, CCL5) and interferon-gamma (IFNG) further supports an effector immune cell role. Crucially, the cluster expresses definitive markers for **gamma-delta T cells (TRGC1, TRGC2)**, alongside components of the **CD8 co-receptor (CD8A, CD8B)**, and a suite of **NK cell receptors (KLRC2, KLRK1, KLRC4, KLRD1, CD160)**. This unique combination strongly points towards **Activated/Tissue-Resident Gamma-Delta T Cells with Cytotoxic Potential** as the most probable cell type. These cells are known to be enriched in mucosal tissues like the large intestine, where they play critical roles in immune surveillance and host defense, often exhibiting features overlapping with both conventional T cells and NK cells. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. Feedback: The annotation is excellent and demonstrates a thorough understanding of single-cell marker interpretation. The step-by-step analysis is clear, logical, and well-supported by the provided marker list. Here's a breakdown of why it passed: 1. **Marker Consistency:** All markers discussed in the annotation are present in the provided marker list. The interpretation of each marker's function and its relevance to the proposed cell types is accurate. 2. **Consistency between Identified Cell Type and Markers:** The final annotation of ""Activated/Tissue-Resident Gamma-Delta T Cells with Cytotoxic Potential"" is highly consistent with the strong expression of TRGC1/TRGC2, CD8A/B, multiple granzymes, perforin, and NK cell receptors. The explanation for why this specific subtype is most likely, considering the co-expression of markers typically associated with NK cells and CD8+ T cells, is well-reasoned. 3. **Mixed Cell Type Consideration:** The annotation explicitly addresses the potential for mixed cell types or cells with overlapping features (e.g., ""overlapping populations of NK cells, CD8+ T cells, and gamma-delta T cells""). It then skillfully navigates this complexity to identify the most probable *specific* subtype, acknowledging the nuances of immune cell biology where distinct lineages can share functional and phenotypic characteristics, especially in activated or tissue-resident states. The ranking of the top 3 probable sub-cell types is also very helpful and demonstrates a comprehensive evaluation. The detailed reasoning for each step, especially the justification for prioritizing gamma-delta T cells due to the definitive TRGC1/TRGC2 markers, is particularly strong. The inclusion of context regarding tissue-resident cells and their potential for expressing immune checkpoints (TIGIT, LAG3) further enhances the annotation's depth and biological relevance. | Formatting Agent: ```json { ""main_cell_type"": ""Cytotoxic Lymphocytes"", ""sub_cell_types"": [ ""Activated/Tissue-Resident Gamma-Delta T Cells (γδ T cells) with Cytotoxic Potential"", ""Activated/Tissue-Resident CD8+ Cytotoxic T Lymphocytes (CTLs)"", ""Natural Killer (NK) Cells"" ], ""possible_mixed_cell_types"": [ ""NK cells"", ""CD8+ T cells"", ""gamma-delta T cells"" ] } ```"
intestinal crypt stem cell,Intestinal Stem Cells (ISCs),"LGR5+ Crypt Base Columnar (CBC) Stem Cells, Secretory Progenitor Cells (early stage), Enterocyte Progenitor Cells (early stage)",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type from the provided marker list: **Step 1. List the Key Functional Markers:** Upon reviewing the provided gene list, many entries are pseudogenes (indicated by 'P' or 'P' followed by a number, or by their genomic locus designation like ALxxxx, ACxxxx). Pseudogenes are generally not reliable markers for cell type identification as they are typically non-functional or have very low, non-specific expression. Therefore, I will focus on the protein-coding genes that are known to be functional. * **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is a well-established and highly specific marker for actively cycling intestinal stem cells (ISCs) in the crypts of Lieberkühn. It is a Wnt target gene and plays a crucial role in maintaining the intestinal epithelium. * **ASCL2 (Achaete-scute homolog 2):** Another key Wnt target gene and a critical transcription factor for intestinal stem cell maintenance and proliferation. It works in conjunction with LGR5 to define the ISC population. * **TDGF1 (Teratocarcinoma-derived growth factor 1, also known as Cripto-1):** While not exclusively a stem cell marker, TDGF1 is expressed in embryonic stem cells and some adult stem cell populations, including intestinal stem cells. It plays roles in cell proliferation, differentiation, and epithelial-mesenchymal interactions, often in conjunction with TGF-beta and Wnt signaling pathways. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. While zinc transporters have diverse roles, some are implicated in cell proliferation and differentiation, and their expression can be altered in various cell states, including stem cells or rapidly dividing cells. Its specific role as a definitive marker here is less strong than LGR5 or ASCL2, but it's a functional gene to note. **Step 2. List the Key Cell Type Markers:** Based on the functional markers identified above, the most prominent cell type markers point towards intestinal stem cells. * **LGR5:** As mentioned, this is the canonical marker for actively cycling intestinal stem cells. Its high expression is a strong indicator. * **ASCL2:** This transcription factor is co-expressed with LGR5 in intestinal stem cells and is essential for their identity and function. * **TDGF1:** While broader in its expression than LGR5/ASCL2, its presence further supports a stem/progenitor cell identity, particularly in the context of intestinal regeneration and development. **Step 3. Cross-reference Known Databases:** * **LGR5:** Widely recognized in scRNA-seq databases (e.g., Human Cell Atlas, Gene Expression Omnibus) as the primary marker for intestinal stem cells in the large intestine and small intestine. * **ASCL2:** Consistently co-expressed with LGR5 in intestinal stem cell clusters across numerous studies. * **TDGF1:** Often found in progenitor populations and stem cells in the gut, though its specificity is lower than LGR5/ASCL2. * **SLC39A2:** While not a primary stem cell marker, its expression has been observed in some intestinal epithelial cells, including progenitor populations, and its role in zinc homeostasis can be important for rapidly dividing cells. The overwhelming evidence from databases and literature confirms that high expression of LGR5 and ASCL2 is characteristic of intestinal stem cells. **Step 4. Determine the Most Probable General Cell Type:** Based on the high expression of **LGR5** and **ASCL2**, the most probable general cell type is **Intestinal Stem Cells (ISCs)**. These cells are responsible for the continuous renewal of the intestinal epithelium. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the strong markers for intestinal stem cells, the sub-types will likely revolve around different states or locations of these stem cells within the intestinal crypt. 1. **Most Likely: LGR5+ Crypt Base Columnar (CBC) Stem Cells:** This is the canonical and most well-characterized intestinal stem cell population. They reside at the very bottom of the crypts of Lieberkühn, intermingled with Paneth cells (in the small intestine) or deep crypt secretory cells (in the large intestine). Their high expression of LGR5 and ASCL2, coupled with their rapid proliferation, perfectly matches the provided markers. The large intestine also contains LGR5+ stem cells, which are crucial for its regeneration. 2. **Second Most Likely: Secretory Progenitor Cells (early stage):** While LGR5+ CBCs are multipotent, they give rise to various progenitor populations. Some early secretory progenitors might still retain some LGR5 expression, especially if they are very close to the stem cell niche or are in an intermediate state of differentiation. ASCL2 also plays a role in secretory lineage commitment. However, as they differentiate further, LGR5 expression typically decreases. Given the high ranking of LGR5, this would be an early progenitor state. 3. **Third Most Likely: Enterocyte Progenitor Cells (early stage):** Similar to secretory progenitors, early enterocyte progenitors, particularly those still close to the crypt base, might exhibit some residual LGR5 expression as they transition from the stem cell state. However, their defining markers would typically shift towards enterocyte-specific genes as they mature. The strong LGR5/ASCL2 signal suggests a closer proximity to the stem cell state than fully committed progenitors. **Most Likely Subtype:** **LGR5+ Crypt Base Columnar (CBC) Stem Cells.** The presence of LGR5 and ASCL2 as highly ranked markers is unequivocally indicative of this specific stem cell population, which is the primary driver of epithelial renewal in the large intestine. **Step 6. Provide a Concise Summary of Your Analysis:** The single-cell cluster from the large intestine tissue is confidently identified as **LGR5+ Crypt Base Columnar (CBC) Stem Cells**. This annotation is strongly supported by the high expression of canonical intestinal stem cell markers, **LGR5** and **ASCL2**, which are critical for stem cell maintenance and proliferation in the intestinal crypts. The presence of **TDGF1** further corroborates a stem/progenitor cell identity. These markers are consistently found in actively cycling intestinal stem cells across various scRNA-seq databases and literature. The top three most probable sub-cell types are LGR5+ Crypt Base Columnar (CBC) Stem Cells (most likely), followed by early secretory progenitor cells, and then early enterocyte progenitor cells, reflecting the differentiation trajectory originating from the LGR5+ stem cell pool. The most likely specific subtype is **LGR5+ Crypt Base Columnar (CBC) Stem Cells** due to the prominence of their defining markers. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. Feedback: The annotation successfully identifies LGR5+ Crypt Base Columnar (CBC) Stem Cells based on the provided marker list. The analysis correctly filters out pseudogenes and focuses on functional markers. The strong emphasis on LGR5 and ASCL2, canonical markers for intestinal stem cells, is well-justified. The consideration of TDGF1 and SLC39A2 as supporting markers, while acknowledging their broader expression, is appropriate. The step-by-step approach, including cross-referencing with known databases, strengthens the validation. The discussion of potential sub-cell types and their differentiation states further demonstrates a thorough understanding of intestinal stem cell biology. | Formatting Agent: ```json { ""main_cell_type"": ""Intestinal Stem Cells (ISCs)"", ""sub_cell_types"": [ ""LGR5+ Crypt Base Columnar (CBC) Stem Cells"", ""Secretory Progenitor Cells (early stage)"", ""Enterocyte Progenitor Cells (early stage)"" ], ""possible_mixed_cell_types"": [] } ```"
intestinal enteroendocrine cell,Enteroendocrine Cells,"L-cells, Enterochromaffin (EC) cells, Paneth-like Enteroendocrine Cells",a broader enteroendocrine progenitor or a cell with a mixed secretory profile,50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** This list is rich in genes associated with neuroendocrine function, hormone production, and secretory processes. * **GCG (Glucagon):** A well-known hormone produced by alpha cells of the pancreas, but also found in enteroendocrine L-cells in the gut, where it's involved in glucose homeostasis and satiety. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** An enzyme involved in the proteolytic processing of prohormones and proneuropeptides into their active forms. Essential for the maturation of many peptide hormones, including GCG, PYY, and INSL5. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone family, involved in stress response, appetite regulation, and gut motility. Often co-expressed with other enteroendocrine markers. * **PYY (Peptide YY):** A gut hormone primarily secreted by L-cells in response to food intake, promoting satiety and slowing gastric emptying. * **INSL5 (Insulin-like 5):** A peptide hormone predominantly expressed in enteroendocrine L-cells of the colon, involved in gut motility and potentially glucose metabolism. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells, involved in the packaging and storage of peptide hormones and neurotransmitters in secretory vesicles. * **SCG2 (Secretogranin II):** Another granin family member, co-stored and co-released with peptide hormones from neuroendocrine cells. * **FEV (FEV Transcription Factor):** A transcription factor primarily expressed in enteroendocrine cells, particularly those producing serotonin and other gut hormones. * **CPLX2 (Complexin 2):** A synaptic protein involved in regulating neurotransmitter release, suggesting a secretory and potentially neuronal-like function. * **NKX2-2 (NK2 Homeobox 2):** A transcription factor crucial for the development and differentiation of various neuroendocrine cell types, including enteroendocrine cells and pancreatic islet cells. * **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, involved in regulated secretion. * **SLC18A1 (Solute Carrier Family 18 Member A1, Vesicular Monoamine Transporter 1 - VMAT1):** Involved in the transport of monoamines (like serotonin) into synaptic vesicles, indicating a capacity for monoamine synthesis and secretion. * **SCG3 (Secretogranin III):** Another granin family member, similar to CHGA and SCG2, indicating neuroendocrine secretory function. * **SCG5 (Secretogranin V, NESP55):** Yet another granin, further supporting neuroendocrine identity. * **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin synthesis, indicating the ability to produce serotonin. * **INSM1 (Insulinoma-associated protein 1):** A key transcription factor for neuroendocrine differentiation, essential for the development of pancreatic islet cells and enteroendocrine cells. * **RTN1 (Reticulon 1):** Involved in endoplasmic reticulum structure and function, potentially related to protein processing and secretion. * **SNAP25 (Synaptosomal-associated protein 25):** A component of the SNARE complex, essential for vesicle fusion and neurotransmitter/hormone release, characteristic of secretory cells. * **CHGB (Chromogranin B):** Another general neuroendocrine marker, similar to CHGA. * **CRMP1 (Collapsin Response Mediator Protein 1):** Involved in neuronal development and axon guidance, suggesting neuronal-like features. * **SLC32A1 (Solute Carrier Family 32 Member A1, Vesicular GABA Transporter - VGAT):** Transports GABA and glycine into synaptic vesicles, suggesting potential inhibitory neurotransmitter handling. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel, crucial for glucose-stimulated insulin secretion in pancreatic beta cells, and also found in some enteroendocrine cells. * **SCT (Secretin):** A hormone produced by S-cells in the duodenum, stimulating bicarbonate and water secretion. While primarily duodenal, its presence suggests a broader enteroendocrine identity. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various endocrine cell types, including pancreatic alpha cells and some enteroendocrine cells. * **PRPH (Peripherin):** An intermediate filament protein found in peripheral neurons and some neuroendocrine cells. * **INA (Internexin Alpha):** Another intermediate filament protein, typically found in neurons. * **SLC5A8 (Solute Carrier Family 5 Member 8):** A sodium-coupled monocarboxylate transporter, involved in nutrient absorption, but also found in some specialized epithelial cells. **Step 2. List the Key Cell Type Markers:** Based on the functional markers, the primary cell type indicated is **enteroendocrine cells**. Many of the genes listed are direct markers for specific enteroendocrine cell subtypes or general enteroendocrine differentiation. * **GCG, PYY, INSL5:** Strong markers for enteroendocrine L-cells, particularly in the colon. * **UCN3:** Often co-expressed with L-cell markers. * **CHGA, CHGB, SCG2, SCG3, SCG5:** General pan-neuroendocrine markers, confirming the neuroendocrine nature. * **PCSK1:** Essential for processing many enteroendocrine hormones. * **FEV, NKX2-2, INSM1, ARX:** Key transcription factors driving enteroendocrine cell development and differentiation. * **TPH1, SLC18A1:** Indicate serotonin-producing capacity, characteristic of enterochromaffin (EC) cells, which are a subtype of enteroendocrine cells. * **SCT:** Marker for S-cells, another enteroendocrine subtype. * **ABCC8:** While prominent in pancreatic beta cells, its presence in the gut context can indicate specific enteroendocrine functions related to glucose sensing. **Step 3. Cross-reference Known Databases:** A quick search in databases like the Human Protein Atlas, PanglaoDB, or single-cell atlases of the large intestine (e.g., Tabula Sapiens, Human Cell Atlas) for these markers consistently points towards **enteroendocrine cells**, particularly those of the L-cell lineage, and potentially other enteroendocrine subtypes. * **GCG, PYY, INSL5, UCN3, CHGA, PCSK1, FEV, NKX2-2, INSM1, TPH1, SCT, ARX** are all highly enriched in various enteroendocrine cell populations across different gastrointestinal segments, with a strong emphasis on L-cells in the colon/large intestine. * The presence of multiple secretogranins (CHGA, CHGB, SCG2, SCG3, SCG5) is a hallmark of neuroendocrine secretory granules. * Genes like SNAP25 and CPLX2, while also found in neurons, are critical for regulated secretion in neuroendocrine cells. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from the marker list, the most probable general cell type is **Enteroendocrine Cells**. The consistent expression of multiple hormones (GCG, PYY, INSL5, UCN3, SCT), processing enzymes (PCSK1), general neuroendocrine markers (CHGA, CHGB, secretogranins), and key transcription factors (FEV, NKX2-2, INSM1, ARX) unequivocally points to this lineage. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the large intestine context and the specific markers: 1. **L-cells (most likely):** * **Strong evidence:** High expression of **GCG, PYY, INSL5, UCN3**. These are canonical markers for L-cells, which are abundant in the large intestine and colon. L-cells are known for co-secreting GLP-1 (encoded by GCG), PYY, and INSL5. * **Supporting evidence:** PCSK1 (for processing these hormones), CHGA/B, secretogranins (general neuroendocrine). 2. **Enterochromaffin (EC) cells:** * **Strong evidence:** Expression of **TPH1** (serotonin synthesis) and **SLC18A1** (VMAT1, serotonin packaging). EC cells are the most numerous enteroendocrine cell type and are responsible for producing serotonin. * **Supporting evidence:** General neuroendocrine markers (CHGA/B, secretogranins), FEV (involved in EC cell differentiation). 3. **Paneth-like Enteroendocrine Cells (or a mixed enteroendocrine population with some S-cell features):** * **Evidence:** The presence of **SCT (Secretin)**, which is typically produced by S-cells primarily in the duodenum. While less common in the large intestine, some enteroendocrine cells can exhibit mixed phenotypes or express markers usually associated with other segments. The term ""Paneth-like"" is sometimes used for enteroendocrine cells with specific secretory granules, though direct Paneth cell markers (e.g., Lyz1, Defa) are not present. However, the overall strong secretory and neuroendocrine profile, combined with a specific hormone like SCT, suggests a distinct enteroendocrine subtype beyond just L and EC cells. * **Alternative interpretation:** This could also represent a broader enteroendocrine progenitor or a cell with a mixed secretory profile, reflecting the plasticity observed in enteroendocrine cells. **Most Likely Subtype:** Based on the prominence and high expression of **GCG, PYY, and INSL5**, the most likely specific subtype is **L-cells**. These cells are highly characteristic of the large intestine and are responsible for key metabolic and satiety signals. The presence of TPH1 and SLC18A1 suggests a potential co-expression of EC cell features or a closely related/transitional state, which is not uncommon in enteroendocrine populations. **Step 6. Provide a Concise Summary of Your Analysis:** The cell cluster exhibits a robust and highly specific gene expression profile indicative of **enteroendocrine cells** within the large intestine. Key markers such as **GCG, PYY, INSL5, UCN3, CHGA, PCSK1, FEV, NKX2-2, and INSM1** collectively point to a neuroendocrine secretory cell type involved in hormone production and release. The presence of **TPH1 and SLC18A1** also suggests serotonin synthesis capabilities. Cross-referencing with established databases strongly supports this annotation. The most probable general cell type is Enteroendocrine Cells. Within this category, the top three most probable subtypes are **L-cells (most likely)** due to the strong expression of GCG, PYY, and INSL5, followed by Enterochromaffin (EC) cells, and potentially a mixed or specialized enteroendocrine cell type expressing SCT. The overall profile is highly consistent with **L-cells**, which are abundant in the large intestine and play crucial roles in gut hormone secretion. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. | Formatting Agent: ```json { ""main_cell_type"": ""Enteroendocrine Cells"", ""sub_cell_types"": [""L-cells"", ""Enterochromaffin (EC) cells"", ""Paneth-like Enteroendocrine Cells""], ""possible_mixed_cell_types"": [""a broader enteroendocrine progenitor or a cell with a mixed secretory profile""] } ```"
monocyte,Neural Crest-Derived Glial Cells,"Schwann Cells / Enteric Glial Cells (EGCs), Neural Crest Progenitors / Immature Glial Cells, Enteric Neurons",,50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I'm ready to analyze this list of highly expressed markers from a single-cell RNA sequencing cluster from human large intestine tissue. I will follow the steps outlined to provide a comprehensive and specific cell type annotation. **Input Marker List (ranked by expression intensity, high to low):** NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2 --- **Step 1: List the Key Functional Markers** This step focuses on genes that indicate general cellular processes, signaling pathways, or broad functional categories, rather than specific cell identities. * **SPP1 (Osteopontin):** A secreted phosphoprotein involved in cell adhesion, migration, and immune responses. Often associated with inflammatory processes, tissue remodeling, and can be expressed by various cell types including macrophages, fibroblasts, and some epithelial cells, as well as neural cells in certain contexts. * **NKAIN3 (Na+/K+ ATPase Interacting 3):** Involved in neuronal differentiation and function, potentially regulating Na+/K+ ATPase activity. Its presence suggests neuronal or neural-like characteristics. * **PLP1 (Proteolipid Protein 1):** A major component of myelin in the central and peripheral nervous systems. Its high expression is a strong indicator of myelinating cells. * **L1CAM (L1 Cell Adhesion Molecule):** A cell adhesion molecule crucial for neuronal development, axon guidance, and fasciculation. Also expressed in some epithelial cancers. Its presence here strongly points towards neural lineage. * **NRXN1 (Neurexin 1):** A presynaptic cell adhesion molecule critical for synapse formation and function. A definitive neuronal marker. * **SYT10 (Synaptotagmin 10):** A member of the synaptotagmin family, involved in regulated exocytosis, often associated with neuronal or neuroendocrine cells. * **SLITRK2 (SLIT and NTRK Like Family Member 2):** A transmembrane protein involved in neuronal development and synapse formation. * **SOX2 (SRY-Box Transcription Factor 2):** A transcription factor critical for maintaining pluripotency and self-renewal in embryonic stem cells, and also expressed in neural stem cells, neural progenitors, and some adult stem cell populations. In the context of the large intestine, it can mark neural crest-derived cells or specific epithelial stem cells. * **FOXD3 (Forkhead Box D3):** A transcription factor involved in embryonic development, particularly in neural crest cell specification and differentiation, and also in maintaining pluripotency. Its presence strongly suggests a neural crest origin. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor-type protein tyrosine phosphatase expressed in the central nervous system, involved in neuronal differentiation and axon guidance. * **GRIK3 (Glutamate Ionotropic Receptor Kainate Type Subunit 3):** A subunit of kainate receptors, which are ionotropic glutamate receptors. Its expression indicates neuronal activity. * **TUBB2B (Tubulin Beta 2B Class IIb):** A beta-tubulin isoform predominantly expressed in neurons, involved in microtubule formation and neuronal migration. * **TTYH1 (Tweety Homolog 1):** A calcium-activated chloride channel, expressed in various tissues, including the nervous system, where it can be involved in neuronal excitability. * **ADARB2 (Adenosine Deaminase RNA Specific B2):** Involved in RNA editing, particularly in the nervous system. * **CDH2 (Cadherin 2 / N-cadherin):** A cell adhesion molecule important for neural cell adhesion, migration, and synapse formation. * **TENM3 (Teneurin Transmembrane Protein 3):** Involved in neuronal connectivity and axon guidance. * **ATP1A2 (ATPase Na+/K+ Transporting Subunit Alpha 2):** A subunit of the Na+/K+ ATPase, highly expressed in astrocytes and neurons, crucial for maintaining ion gradients. * **NRXN3 (Neurexin 3):** Another member of the neurexin family, involved in synapse formation. * **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for glial cell line-derived neurotrophic factor (GDNF) family ligands, important for neuronal survival and differentiation. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and neuronal development. **Summary of Functional Markers:** A striking number of these genes are directly involved in neuronal structure, function, development, and cell adhesion (e.g., L1CAM, NRXN1, SLITRK2, SYT10, GRIK3, TUBB2B, CDH2, TENM3, NRXN3, GFRA2, FLRT1). The presence of myelin-related genes (PLP1) and neural crest/stem cell markers (SOX2, FOXD3) is also highly significant. --- **Step 2: List the Key Cell Type Markers** This step focuses on genes that are highly specific to particular cell types or lineages. * **PLP1 (Proteolipid Protein 1):** A canonical marker for oligodendrocytes (in CNS) and Schwann cells (in PNS), which are myelinating glial cells. Its high expression is a very strong indicator of these cell types. * **L1CAM (L1 Cell Adhesion Molecule):** While functional, it's also a strong marker for neurons and neural crest-derived cells. * **SOX10 (SRY-Box Transcription Factor 10):** A master regulator transcription factor for neural crest development. It is a definitive marker for neural crest stem cells, Schwann cells, satellite glial cells, and melanocytes. Its presence is extremely strong evidence for a neural crest lineage. * **SOX2 (SRY-Box Transcription Factor 2):** As mentioned, a marker for neural stem cells/progenitors and neural crest-derived cells. * **FOXD3 (Forkhead Box D3):** Another critical transcription factor for neural crest development and specification. Its co-expression with SOX10 is highly indicative of neural crest origin. * **CDH19 (Cadherin 19):** A cadherin family member, less commonly discussed but has been implicated in neural development and some cancers. Its specific cell type association is less definitive than SOX10 or PLP1 but aligns with neural context. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** Primarily expressed in the central nervous system, particularly by neural stem cells, astrocytes, and oligodendrocytes. * **MEGF10 (Multiple Epidermal Growth Factor Like Domains 10):** Expressed in various tissues, including the nervous system, where it can play roles in cell adhesion and differentiation. Less specific but consistent with neural context. * **CHL1 (Cell Adhesion Molecule L1 Like):** A neural cell adhesion molecule, closely related to L1CAM, involved in neuronal migration and axon guidance. * **CMTM5 (Chemokine Like Receptor 5):** While broadly expressed, it has been linked to neural development and function in some contexts. * **LPL (Lipoprotein Lipase):** Involved in lipid metabolism. While not a primary neural marker, Schwann cells are highly metabolically active and require lipids for myelin synthesis. * **CHADL (Chondroadherin Like):** Less specific, but some chondroadherin-like proteins have been found in the nervous system. * **FGFBP2 (Fibroblast Growth Factor Binding Protein 2):** Can be expressed by various cell types, including some immune cells and stromal cells, but its role in neural context is less defined. **Summary of Cell Type Markers:** The presence of **SOX10**, **PLP1**, **L1CAM**, **SOX2**, and **FOXD3** together is an exceptionally strong signature for cells of neural crest origin, specifically myelinating glial cells (Schwann cells) or their progenitors. --- **Step 3: Cross-reference Known Databases** I will mentally cross-reference these markers with common scRNA-seq atlases (e.g., Human Cell Atlas, specific gut atlases) and literature. * **SOX10, PLP1, L1CAM, FOXD3, SOX2, NRXN1, CDH2, TUBB2B:** This combination is a classic signature for cells of the peripheral nervous system (PNS), particularly Schwann cells and their precursors, or enteric glial cells (EGCs), which are neural crest-derived. * **PLP1:** In the PNS, PLP1 is a hallmark of myelinating Schwann cells. * **SOX10:** The master regulator for neural crest development and a key marker for Schwann cells and enteric glial cells. * **L1CAM, NRXN1, CDH2, TUBB2B:** These are all highly expressed in neurons and neural support cells, consistent with a neural lineage. * **SPP1:** While often associated with inflammation, SPP1 has also been reported in some neural populations and can be involved in neural repair or response to injury. * **Large Intestine Context:** The large intestine is richly innervated by the enteric nervous system (ENS), which is derived from the neural crest. The ENS contains neurons and enteric glial cells (EGCs). EGCs share many characteristics with Schwann cells, including the expression of SOX10 and the ability to myelinate in some contexts (though less extensively than PNS Schwann cells). Based on this cross-referencing, the marker profile is highly consistent with neural crest-derived glial cells, specifically Schwann cells or enteric glial cells. --- **Step 4: Determine the Most Probable General Cell Type** Given the overwhelming presence of neural development, adhesion, and myelin-related genes, particularly the co-expression of **SOX10**, **PLP1**, **L1CAM**, **FOXD3**, and neuronal adhesion molecules, the most probable general cell type is **Neural Crest-Derived Glial Cells**. --- **Step 5: Identify the Top 3 Most Probable Sub Cell Types** 1. **Most Likely: Schwann Cells / Enteric Glial Cells (EGCs)** * **Reasoning:** The combination of **SOX10** (master regulator for neural crest, definitive Schwann/EGC marker), **PLP1** (myelin component, highly expressed in Schwann cells), **L1CAM** (neural adhesion), **FOXD3** (neural crest), and numerous neuronal adhesion/synaptic genes (NRXN1, SLITRK2, SYT10, CDH2, TENM3, NRXN3) strongly points to myelinating or non-myelinating Schwann cells, or their enteric nervous system counterparts, enteric glial cells. EGCs are functionally diverse and share many markers with Schwann cells, acting as support cells for enteric neurons. The large intestine is rich in ENS, making EGCs a very strong candidate. The high expression of PLP1 suggests a myelinating phenotype, which is characteristic of some Schwann cells in the PNS, and EGCs can also form myelin-like structures. 2. **Second Most Likely: Neural Crest Progenitors / Immature Glial Cells** * **Reasoning:** The presence of **SOX2** and **FOXD3** alongside SOX10 suggests a potential progenitor state or a less differentiated glial cell. While SOX10 and PLP1 are strong indicators of differentiated glia, the overall profile could also capture cells in the process of differentiating from a neural crest stem cell pool into mature glial cells. These cells would still express many neural adhesion and developmental genes. 3. **Third Most Likely: Enteric Neurons (with glial contamination or shared markers)** * **Reasoning:** Many of the listed markers (L1CAM, NRXN1, SYT10, SLITRK2, SOX2, GRIK3, TUBB2B, TTYH1, ADARB2, CDH2, TENM3, ATP1A2, NRXN3, GFRA2, FLRT1) are also expressed by neurons. However, the very high expression of **PLP1** and **SOX10** (especially PLP1) makes pure neurons less likely as the primary identity of the cluster, as PLP1 is a glial-specific myelin protein. If this were a neuronal cluster, we would expect to see more canonical neuronal markers like *MAP2*, *NEFH*, *RBFOX3 (NeuN)*, *SYP*, *SNAP25*, etc., higher up in the list, and PLP1 would likely be absent or very low. However, given the close developmental and functional relationship between neurons and glia in the ENS, some shared markers are expected, and a small degree of neuronal contamination or expression of these genes in glial cells cannot be entirely ruled out. **Most Likely Subtype:** Based on the robust and high expression of **SOX10** and **PLP1**, the most likely subtype is **Schwann Cells / Enteric Glial Cells (EGCs)**, with a strong indication of a myelinating or myelin-associated phenotype. Given the tissue is large intestine, **Enteric Glial Cells** are the most specific and appropriate annotation. --- **Step 6: Provide a Concise Summary of Your Analysis** This cell cluster from the human large intestine exhibits a highly distinctive gene expression profile strongly indicative of **Enteric Glial Cells (EGCs)**. The most compelling evidence comes from the co-expression of key neural crest and glial markers: **SOX10** (a master regulator for neural crest and definitive glial marker), and **PLP1** (a major component of myelin, characteristic of Schwann cells and some EGCs). Further support is provided by the presence of numerous genes involved in neural development, cell adhesion, and synaptic function, such as **L1CAM**, **NRXN1**, **FOXD3**, **SOX2**, **SLITRK2**, **SYT10**, **CDH2**, and **TUBB2B**. While some markers could overlap with neurons or progenitors, the robust expression of PLP1 and SOX10 firmly places this cluster within the glial lineage. The high ranking of PLP1 suggests these EGCs may have myelinating or myelin-associated functions, consistent with the diverse roles of glia in the enteric nervous system. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. Feedback: The annotation is exceptionally thorough and well-reasoned. The detailed breakdown of functional and cell-type specific markers, combined with the cross-referencing to known biological contexts (human large intestine, ENS, neural crest development), provides a strong and convincing argument for the final annotation. The consideration of potential mixed cell types and the clear justification for prioritizing Enteric Glial Cells over other neural cell types (like neurons or less differentiated progenitors) is excellent. The identification of SOX10 and PLP1 as key discriminators is particularly insightful. | Formatting Agent: ```json { ""main_cell_type"": ""Neural Crest-Derived Glial Cells"", ""sub_cell_types"": [ ""Schwann Cells / Enteric Glial Cells (EGCs)"", ""Neural Crest Progenitors / Immature Glial Cells"", ""Enteric Neurons"" ], ""possible_mixed_cell_types"": [] } ```"
plasma cell,Plasma Cell,"IgA-secreting Plasma Cells, IgG-secreting Plasma Cells, IgM-secreting Plasma Cells",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type from the provided scRNA-seq marker list: ## Step 1: List the Key Functional Markers The most striking feature of this marker list is the overwhelming presence of immunoglobulin genes. These genes are directly involved in antibody production and secretion, which is the primary function of plasma cells. * **Immunoglobulin Light Chain Genes:** * **IGLL5 (Immunoglobulin Lambda-like polypeptide 5):** A pseudogene or a gene encoding a protein involved in B cell development and differentiation, often upregulated in plasma cells. * **IGLV6-57, IGLC3, IGLC2, IGLV3-1, IGLV2-11 (Immunoglobulin Lambda Variable and Constant Chains):** These are components of the immunoglobulin lambda light chain, crucial for antibody structure and function. * **IGKC, IGKV4-1, IGKV1-5, IGKV3-20 (Immunoglobulin Kappa Constant and Variable Chains):** These are components of the immunoglobulin kappa light chain, also crucial for antibody structure and function. * **Immunoglobulin Heavy Chain Genes:** * **JCHAIN (Joining Chain):** A polypeptide that links monomeric immunoglobulin (IgM and IgA) units into polymeric forms (pentameric IgM and dimeric IgA), characteristic of secreted antibodies. * **IGHV3-7, IGHG1, IGHV3-23, IGHG3, IGHV3-74, IGHM, IGHA1, IGHA2 (Immunoglobulin Heavy Chain Variable, Gamma, Mu, and Alpha Chains):** These represent various heavy chain constant and variable regions, indicating the production of different antibody isotypes (IgG1, IgG3, IgM, IgA1, IgA2). The presence of multiple isotypes suggests a mature, differentiated B cell lineage. * **Plasma Cell Differentiation/Function Markers:** * **TNFRSF17 (B Cell Maturation Antigen - BCMA):** A receptor highly expressed on plasma cells and essential for their survival and differentiation. * **MZB1 (Marginal Zone B and B1 Cell Specific Protein 1):** A protein involved in immunoglobulin secretion and endoplasmic reticulum stress response, highly expressed in plasma cells. * **DERL3 (Derlin 3):** Involved in endoplasmic reticulum-associated degradation (ERAD), which is crucial for handling the high protein synthesis load in plasma cells. * **GPRC5D (G Protein-Coupled Receptor Class C Group 5 Member D):** A receptor highly expressed on plasma cells, often targeted in multiple myeloma. * **FCRL5 (Fc Receptor Like 5):** An inhibitory Fc receptor expressed on a subset of B cells and plasma cells, involved in regulating B cell activation. ## Step 2: List the Key Cell Type Markers Given the context of the large intestine, we need to consider cell types typically found there. However, the overwhelming majority of the top markers are directly related to immunoglobulin production and plasma cell function, making it highly specific. * **Plasma Cell Specific Markers (overlapping with functional markers):** * **IGLL5, JCHAIN, TNFRSF17, MZB1, DERL3, GPRC5D, FCRL5, and all the various immunoglobulin heavy and light chain genes.** These are the defining markers of plasma cells. * **Other potentially relevant markers (less specific but worth noting):** * **MYL2 (Myosin Light Chain 2):** While broadly expressed, it can be found in various cell types. Its high ranking here is less indicative of a specific cell type other than the dominant immunoglobulin genes. * **CCL3 (Chemokine (C-C motif) ligand 3):** A chemokine that attracts various immune cells. Its presence suggests an immune cell, but not specifically a plasma cell. * **LILRB4 (Leukocyte Immunoglobulin Like Receptor B4):** An inhibitory receptor expressed on myeloid cells, but also found on some B cells and plasma cells. * **CCR10 (C-C Chemokine Receptor Type 10):** Expressed on various immune cells, including some B cells and plasma cells, and involved in homing to mucosal tissues. * **APOBEC3A (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-like 3A):** An enzyme involved in innate immunity and DNA editing, expressed in various immune cells. The remaining markers (e.g., AC026369.3, ANKRD36BP2, AMPD1, LINC02362, AL391056.1, BMP6, UBE2QL1, LINC00309, AL133467.1, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, BFSP2, AC106897.1) are either uncharacterized LINC RNAs, pseudogenes, or genes with broad expression patterns that do not strongly point to a specific cell type in this context, especially when compared to the highly specific immunoglobulin and plasma cell markers. ## Step 3: Cross-reference Known Databases Cross-referencing these markers with scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, ImmGen) and literature consistently points to plasma cells. * **Immunoglobulin genes (IGHG1, IGHA1, IGHM, IGLC, IGKC, etc.) and JCHAIN:** Universally recognized as definitive markers for antibody-producing cells (plasma cells). * **TNFRSF17 (BCMA):** A canonical plasma cell marker, crucial for their survival. * **MZB1:** Another well-established plasma cell marker, involved in antibody secretion. * **GPRC5D:** Increasingly recognized as a specific marker for plasma cells, particularly in the context of multiple myeloma and normal plasma cells. * **DERL3:** Often found upregulated in cells with high secretory activity, like plasma cells. * **FCRL5:** While also found on some B cells, its co-expression with other plasma cell markers supports a plasma cell identity. The co-expression of multiple heavy and light chain genes, along with JCHAIN, TNFRSF17, MZB1, and GPRC5D, forms an unmistakable signature of plasma cells. The presence of different immunoglobulin isotypes (IgG, IgA, IgM) further indicates a mature, class-switched plasma cell population. ## Step 4: Determine the Most Probable General Cell Type Based on the overwhelming evidence from the key functional and cell type markers, the most probable general cell type is **Plasma Cell**. The high expression of numerous immunoglobulin heavy and light chain genes, along with genes critical for antibody assembly (JCHAIN), secretion (MZB1, DERL3), and plasma cell survival/differentiation (TNFRSF17, GPRC5D), leaves little doubt. ## Step 5: Identify the Top 3 Most Probable Sub Cell Types Given that the tissue is the large intestine, plasma cells here are predominantly involved in mucosal immunity. 1. **Most Likely: IgA-secreting Plasma Cells (Mucosal Plasma Cells):** * **Reasoning:** The large intestine is a major mucosal site where IgA is the predominant antibody isotype, playing a critical role in gut immunity. The presence of **IGHA1** and **IGHA2** (Immunoglobulin Alpha Heavy Chain) strongly supports this. The high ranking of JCHAIN also aligns with polymeric IgA secretion. * **Supporting Markers:** IGHA1, IGHA2, JCHAIN. * **Consideration:** While IgG (IGHG1, IGHG3) and IgM (IGHM) are also present, IgA is typically the most abundant in the gut lamina propria. 2. **Second Most Likely: IgG-secreting Plasma Cells:** * **Reasoning:** While IgA dominates mucosal sites, IgG-secreting plasma cells are also present in the gut lamina propria and contribute to local immunity. The presence of **IGHG1** and **IGHG3** (Immunoglobulin Gamma Heavy Chain) indicates the production of IgG antibodies. * **Supporting Markers:** IGHG1, IGHG3. 3. **Third Most Likely: IgM-secreting Plasma Cells:** * **Reasoning:** IgM-secreting plasma cells are generally less abundant than IgA or IgG plasma cells in the mature gut, but they represent an early stage of B cell differentiation or a specific subset. The presence of **IGHM** (Immunoglobulin Mu Heavy Chain) suggests the production of IgM. * **Supporting Markers:** IGHM. **Most Likely Subtype:** Based on the context of the large intestine and the presence of **IGHA1** and **IGHA2**, the most likely subtype is **IgA-secreting Plasma Cells (Mucosal Plasma Cells)**. The co-expression of IgG and IgM indicates a heterogeneous population of plasma cells, which is expected in a dynamic immune environment like the gut, but IgA is typically the dominant isotype in this location. ## Step 6: Provide a Concise Summary of Your Analysis The cell cluster is definitively identified as **Plasma Cells**. This annotation is strongly supported by the high and widespread expression of numerous immunoglobulin genes (heavy chains: IGHG1, IGHG3, IGHM, IGHA1, IGHA2; light chains: IGLV, IGLC, IGKV, IGKC) and the joining chain (JCHAIN), which are all critical for antibody production and secretion. Further corroborating this identification are key plasma cell differentiation and survival markers such as TNFRSF17 (BCMA), MZB1, DERL3, GPRC5D, and FCRL5. Given the tissue origin (large intestine), the presence of IGHA1 and IGHA2 strongly suggests that the most probable subtype is **IgA-secreting Plasma Cells (Mucosal Plasma Cells)**, which are crucial for gut immunity. Other IgG and IgM secreting plasma cells are also likely present, contributing to the overall immune response. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED. Feedback: The annotation is exceptionally thorough and accurate. The step-by-step analysis clearly identifies the key functional and cell type markers, consistently linking them to plasma cell identity. The consideration of the tissue context (large intestine) to infer the most probable subtypes (IgA-secreting plasma cells) is a strong point. The marker consistency is excellent, with all discussed markers explicitly present in the provided list. The analysis also appropriately flags less specific markers without letting them detract from the strong evidence for plasma cells. No mixed cell types are strongly supported, and the annotation correctly identifies the heterogeneity within plasma cells (IgA, IgG, IgM secreting) as expected for a mature immune response. | Formatting Agent: ```json { ""main_cell_type"": ""Plasma Cell"", ""sub_cell_types"": [""IgA-secreting Plasma Cells"", ""IgG-secreting Plasma Cells"", ""IgM-secreting Plasma Cells""], ""possible_mixed_cell_types"": [] } ```"
transit amplifying cell of large intestine,Proliferating Cells,"Intestinal Epithelial Progenitor Cells / Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), Activated Immune Cells (e.g., Lymphocytes) or Fibroblasts undergoing proliferation",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster in human large intestine tissue to identify the cell type. Here's my step-by-step analysis: ### Step 1: List the Key Functional Markers The vast majority of the genes in this list are intimately involved in cell cycle progression, DNA replication, and mitosis. This immediately points towards a highly proliferative cell population. * **Cell Cycle Regulation & Mitosis:** * **UBE2C:** Ubiquitin-conjugating enzyme E2 C, crucial for anaphase-promoting complex/cyclosome (APC/C) activation, regulating mitotic progression. * **PBK (PDZ-binding kinase):** A mitotic kinase involved in cell cycle progression, particularly G2/M transition and mitosis. * **AURKB (Aurora Kinase B):** A key mitotic kinase regulating chromosome segregation, cytokinesis, and spindle assembly checkpoint. * **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization and chromosome segregation during mitosis. * **CKAP2L (Cytoskeleton Associated Protein 2 Like):** Involved in microtubule organization and cell division. * **KIF2C (Kinesin Family Member 2C), KIF15, KIF18B:** Kinesin motor proteins essential for spindle dynamics, chromosome movement, and cytokinesis during mitosis. * **BIRC5 (Survivin):** An anti-apoptotic protein and a key component of the chromosomal passenger complex, essential for proper chromosome segregation and cytokinesis. * **SPC25, SPC24 (NDC80 complex components):** Part of the kinetochore, crucial for microtubule attachment and chromosome segregation. * **ASPM (Abnormal Spindle Microtubule Assembly):** Essential for normal spindle function and neurogenesis, often associated with proliferation. * **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis, specifically abscission. * **DEPDC1 (DEP Domain Containing 1):** Associated with cell proliferation and often overexpressed in various cancers. * **MKI67 (Ki-67):** A classic and widely used marker for cell proliferation, expressed during active phases of the cell cycle (G1, S, G2, M). * **CDC45 (Cell Division Cycle 45):** Essential for initiation of DNA replication and progression through S phase. * **CDCA5 (Cell Division Cycle Associated 5):** Involved in sister chromatid cohesion and chromosome segregation. * **TOP2A (DNA Topoisomerase II Alpha):** Essential for DNA replication, transcription, and chromosome segregation by resolving topological problems in DNA. * **PCLAF (PCNA-associated factor):** Involved in DNA replication and repair. * **MND1 (Meiotic Nuclear Division 1 Homolog):** Involved in homologous recombination during meiosis and DNA repair, but also implicated in mitotic processes. * **RRM2 (Ribonucleotide Reductase M2):** Catalyzes the rate-limiting step in dNTP synthesis, essential for DNA replication. * **CCNB2 (Cyclin B2):** A mitotic cyclin, crucial for entry into and progression through mitosis. * **NUF2 (NUF2 Kinetochore Complex Component):** Part of the NDC80 complex, essential for kinetochore function and chromosome segregation. * **SKA3, SKA1 (Spindle and Kinetochore Associated 3/1):** Components of the SKA complex, essential for stable microtubule-kinetochore attachments. * **DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog):** Involved in DNA damage response and cell cycle control. * **PKMYT1 (Protein Kinase, Myelin Transcription Factor 1):** A kinase that phosphorylates and inhibits CDK1, involved in G2/M checkpoint. * **CDCA3 (Cell Division Cycle Associated 3):** Involved in mitotic progression. * **TTK (Dual Specificity Tyrosine Regulated Kinase):** A checkpoint kinase involved in the spindle assembly checkpoint. * **PLK1 (Polo-like Kinase 1):** A master regulator of multiple mitotic events, including centrosome maturation, spindle assembly, and cytokinesis. * **CDK1 (Cyclin Dependent Kinase 1):** The master regulator of entry into and progression through mitosis. * **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis, a marker of cell proliferation. * **POLQ (DNA Polymerase Theta):** Involved in DNA repair pathways, including alternative end-joining. * **GTSE1 (G2 and S-phase expressed 1):** Involved in cell cycle progression and DNA damage response. * **OIP5 (OPA-Interacting Protein 5):** Involved in mitotic spindle formation and chromosome segregation. * **FOXM1 (Forkhead Box M1):** A key transcription factor that regulates the expression of numerous genes involved in cell cycle progression, DNA replication, and mitosis. Often considered a master regulator of proliferation. * **TROAP (Trophinin Associated Protein):** Involved in cytokinesis. * **NEK2 (NIMA Related Kinase 2):** Involved in centrosome separation and spindle formation. * **CDC25C (Cell Division Cycle 25C):** A phosphatase that activates CDK1, promoting entry into mitosis. * **NCAPG (Non-SMC Condensin I Complex Subunit G):** A component of the condensin complex, essential for chromosome condensation. * **PIMREG (PIM Kinase Interacting Cell Cycle Regulator):** Involved in cell cycle regulation. * **GINS2 (GINS Complex Subunit 2):** A component of the GINS complex, essential for DNA replication initiation and fork progression. * **RAD51AP1 (RAD51 Associated Protein 1):** Involved in homologous recombination and DNA repair. * **CDT1 (Chromatin Licensing And DNA Replication Factor 1):** Essential for DNA replication initiation. * **CCNA2 (Cyclin A2):** A cyclin involved in both S-phase and M-phase progression. * **Other/Less Specific:** * **HJURP (Holliday Junction Recognition Protein):** Involved in centromere assembly and maintenance. * **ZNF695 (Zinc Finger Protein 695):** Less directly linked to core cell cycle machinery, but some zinc finger proteins are involved in transcriptional regulation of cell cycle genes. * **IQGAP3 (IQ Motif And GTPase Activating Protein 3):** Involved in cell proliferation and migration. * **DIAPH3 (Diaphanous Related Formin 3):** Involved in actin cytoskeleton organization and cytokinesis. ### Step 2: List the Key Cell Type Markers Given the overwhelming presence of proliferation-associated genes, there are no specific ""tissue cell type"" markers in this list that would define a mature, differentiated cell type (e.g., enterocytes, goblet cells, T cells). Instead, the markers are indicative of a *state* rather than a *terminal identity*. However, in the context of the large intestine, highly proliferative cells are typically found in specific niches. ### Step 3: Cross-reference Known Databases Cross-referencing these markers with scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker) and literature for large intestine tissue consistently points to actively dividing cells. * **MKI67, TOP2A, BIRC5, AURKB, CDK1, CCNB2, FOXM1, RRM2, TK1, PLK1, UBE2C, CDC25C, CDC45, CDT1, CCNA2, GINS2, PCLAF, DTL, NCAPG, KIFs, SPCs, CEP55, DLGAP5, ASPM, HJURP, CENPA, PBK, CDCA3, CDCA5, DEPDC1, TTK, OIP5, GTSE1, PIMREG, RAD51AP1, MND1, SKA1, SKA3, TROAP, NEK2, CKAP2L, IQGAP3, DIAPH3, POLQ, ZNF695.** * These genes are universally recognized as markers of the cell cycle and proliferation across various tissues and species. * In the large intestine, these gene sets are characteristic of **progenitor cells** or **stem cells** located in the crypts of Lieberkühn, which are responsible for continuous epithelial renewal. ### Step 4: Determine the Most Probable General Cell Type Based on the pervasive expression of genes involved in DNA replication, cell cycle progression, and mitosis, the most probable general cell type is **Proliferating Cells**. These are cells actively undergoing cell division. ### Step 5: Identify the Top 3 Most Probable Sub Cell Types Considering the context of the human large intestine, proliferating cells are primarily found within the crypts. 1. **Most Likely: Intestinal Epithelial Progenitor Cells / Transit-Amplifying (TA) Cells:** These cells are highly proliferative, located in the crypts, and are responsible for generating the various differentiated epithelial cell types (enterocytes, goblet cells, enteroendocrine cells, Paneth cells in the small intestine, but not typically in the large intestine). The sheer number and high expression of cell cycle genes strongly support this. TA cells undergo several rounds of division before differentiating. 2. **Second Most Likely: Intestinal Stem Cells (ISCs):** While ISCs are also highly proliferative and reside at the base of the crypts, they typically exhibit a more quiescent or slowly cycling state compared to the rapidly dividing TA cells, especially the Lgr5+ ISCs. However, when actively dividing, their gene expression profile would overlap significantly with TA cells. The very high expression of so many cell cycle genes might lean more towards TA cells, which are designed for rapid amplification. 3. **Third Most Likely: Activated Immune Cells (e.g., Lymphocytes) or Fibroblasts undergoing proliferation (e.g., in wound healing/disease):** In certain contexts (inflammation, disease, or specific immune responses), immune cells (like T cells or B cells) or fibroblasts can become highly proliferative. However, the marker list is almost exclusively composed of universal cell cycle genes, with no specific immune cell markers (e.g., CD3, CD8, CD19) or fibroblast markers (e.g., COL1A1, DCN, ACTA2). Therefore, this is less likely to be the primary identity, but proliferation can occur in these cell types. Given the lack of specific markers, this is a much weaker possibility compared to epithelial progenitors. **Most Likely Subtype:** **Intestinal Epithelial Transit-Amplifying (TA) Cells.** The extensive list of highly expressed mitotic and cell cycle genes is a hallmark of these rapidly dividing cells that are expanding the cell population for epithelial renewal. ### Step 6: Provide a Concise Summary of Your Analysis The single-cell cluster from human large intestine tissue is unequivocally identified as **Proliferating Cells**. The marker list is dominated by genes essential for DNA replication, cell cycle progression, and mitosis, including classic proliferation markers such as MKI67, TOP2A, BIRC5, AURKB, CDK1, CCNB2, FOXM1, and numerous kinesins (KIFs) and kinetochore components (SPCs, NUF2). In the context of the large intestine, this expression profile is characteristic of cells undergoing rapid division to maintain tissue homeostasis. The most probable specific subtype is **Intestinal Epithelial Transit-Amplifying (TA) Cells**, which are highly proliferative progenitor cells responsible for generating the differentiated epithelial lineages within the crypts of Lieberkühn. Intestinal Stem Cells (ISCs) are also a possibility, but the sheer breadth and intensity of proliferation markers lean more towards the rapidly expanding TA population. Other proliferating cell types (e.g., immune cells, fibroblasts) are less likely given the absence of their specific lineage markers. FINAL ANNOTATION COMPLETED. | Coupling Validator: Validation result: VALIDATION PASSED. | Formatting Agent: ```json { ""main_cell_type"": ""Proliferating Cells"", ""sub_cell_types"": [ ""Intestinal Epithelial Progenitor Cells / Transit-Amplifying (TA) Cells"", ""Intestinal Stem Cells (ISCs)"", ""Activated Immune Cells (e.g., Lymphocytes) or Fibroblasts undergoing proliferation"" ], ""possible_mixed_cell_types"": [] } ```"
